Device and digital-health firms are looking toward US FDA's imminent launch of the novel pre-certification program as an opportunity to streamline the path to market for new software. FDA has been regularly engaging stakeholders during the pilot stage with a goal to quickly get the first iteration of the program off the ground.
As part of the effort, the agency says it is carefully designing the program to fit within its current legal authorities. (Also see "Size Doesn't Matter: US FDA Refines Dig-Health Pre-Cert Model" - Medtech Insight, 20 June, 2018.) But not everyone agrees it is meeting that standard
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?